Current Investing Position
OrbiMed Managing Partner
Investment Range
$1M - $75.0M
Sweet Spot
$4.0M
Investments On Record
63
Current Fund Size
$18B
Carl Gordon is on these Sector & Stage Rankings
Carl Gordon's Investments On Record (30)
Company | StageDateRound Size | Total Raised |
---|---|---|
Alterome Therapeutics | Series BApr 2024$130M Series ANov 2022$35M Series AJan 2022$64M | $230M |
ENYO Pharma | Series CJan 2024$43M Series BJun 2018$47M | $90M |
BlossomHill Therapeutics | Series BJan 2024$100M Series AMar 2021$71M | $170M |
Star Therapeutics | Series CSep 2023$90M | $90M |
ADARx Pharmaceuticals | Series CAug 2023$200M Series BJan 2023$46M Series BSep 2021$75M | $320M |
Garuda Therapeutics | Series BFeb 2023$62M Series ASep 2021$72M | $130M |
ArriVent Biopharma | Series BDec 2022$160M | $160M |
MBX Biosciences | Series BNov 2022$120M Series AJul 2020$35M | $150M |
Investors who invest with Carl Gordon